Molecular diagnosis of non-deletion SMA patients using quantitative PCR of SMN exon 7 (original) (raw)
ABSTRACT
The telomeric survival motor neuron (SMNT gene is a valuable molecular diagnostic tool for childhood-onset spinal muscular atrophy (SMA) as homozygous deletions of SMNT exon 7 (Δ7SMNT) are present in ∼94% of patients. In this report, we provide the first comprehensive study of 32 unrelated non-deletion SMA patients. Quantitative polymerase chain reaction (PCR) studies established that 90% had two intact copies of SMNT exon 7 suggesting that that these patients do not have 5q SMA. Once 5q SMA is confirmed, the SMNT gene can be screened for subtle mutations. Using single strand conformation analysis, we identified two missense mutations (P245L and Y272C) in exon 6 of the SMNT gene of two SMA patients shown to have a single copy of SMNT exon 7. Y272 is most likely critical for SMNT function as it is target for recurring mutations and is associated with type I SMA. These results emphasize the need for dosage analysis in the differential diagnosis of 5q SMA in non-deletion patients, consistent with extensive clinical heterogeneity and some genetic heterogeneity in this disease. Homozygosity or heterozygosity for a Δ7SMNT allele confirms the diagnosis of 5q SMA with greater precision than clinical examination alone.
Access this article
Subscribe and save
- Get 10 units per month
- Download Article/Chapter or eBook
- 1 Unit = 1 Article or 1 Chapter
- Cancel anytime Subscribe now
Buy Now
Price excludes VAT (USA)
Tax calculation will be finalised during checkout.
Instant access to the full article PDF.
Similar content being viewed by others
Author information
Authors and Affiliations
- Department of Genetics, Hopital Sainte-Justine, Montréal, Québec, Canada, , , , , , CA
C.F. Rochette & L.R. Simard - Department of Genetics, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada, , , , , , CA
L.C. Surh - Department of Genetics, Hospital for Sick Children, Toronto, Ontario, Canada, , , , , , CA
P.N. Ray - Department of Pathology, The Ohio State University, Columbus, Ohio, USA, , , , , , US
P.E. McAndrew & T.W. Prior - Department of Neurology, The Ohio State University, Columbus, Ohio, USA, , , , , , US
A.H.M. Burghes - Department of Pediatrics, Hopital Sainte-Justine, Montréal, Québec, Canada, , , , , , CA
M. Vanasse
Authors
- C.F. Rochette
You can also search for this author inPubMed Google Scholar - L.C. Surh
You can also search for this author inPubMed Google Scholar - P.N. Ray
You can also search for this author inPubMed Google Scholar - P.E. McAndrew
You can also search for this author inPubMed Google Scholar - T.W. Prior
You can also search for this author inPubMed Google Scholar - A.H.M. Burghes
You can also search for this author inPubMed Google Scholar - M. Vanasse
You can also search for this author inPubMed Google Scholar - L.R. Simard
You can also search for this author inPubMed Google Scholar
Additional information
Received July 14, 1997; Revised and Accepted July 15, 1997
Rights and permissions
About this article
Cite this article
Rochette, C., Surh, L., Ray, P. et al. Molecular diagnosis of non-deletion SMA patients using quantitative PCR of SMN exon 7.Neurogenetics 1, 141–147 (1997). https://doi.org/10.1007/s100480050021
- Issue Date: November 1997
- DOI: https://doi.org/10.1007/s100480050021